retatrutide triple agonist obesity 🚨 Today, retatrutide, the GIP/GLP-1/glucagon agonist, just delivered TRIUMPH-2 top-line results. A study in those with concurrent and type 2 diabetes. 📊 Mean body weight change at 80 weeks: ⬇️ Lilly's triple agonist, retatrutide, delivered

EFSA Panel on Nutrition Novel Foods and Food Allergens

Are both FDA-approved for obesity

The FDA perspective on compounded semaglutide Understanding the regulatory landscape helps you make informed decisions about using compounded sublingual drops

Zincs role in DNA repair promotes cellular health by preserving the integrity of genetic information and minimizing damage brought on by oxidative stress (155)

397 Genes involved in the manifestation of proliferative diabetic retinopathy in people with diabetic retinopathy Q

Eur J Pharmacol 667(13):322329 Jelovac N, Sikiric P, Rucman R et al (1998) A novel pentadecapeptide, BPC 157, blocks the stereotypy produced acutely by amphetamine and the development of haloperidol-induced supersensitivity to amphetamine